By Admin at 13 Apr 2016

Patients with acute lymphoblastic leukemia (ALL), non-Hodgkin lymphoma and chronic lymphocytic leukemia are taking part in the trial and received an experimental “living” immunotherapy. The results have so far been “extraordinary,” according to the researchers, including among some patients that were initially given only months to live.

By Admin at 8 Feb 2016

Not all cancer patients are candidates for chemo alternatives, but some, like those with chronic lymphocytic leukemia (CLL), may fare better by skipping chemo and instead taking anti-cancer drugs.

By Admin at 23 Oct 2015

Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in adults, and although survival rates vary from two to 20 years after diagnosis, it is considered incurable with conventional therapies. While stem cell transplants may provide a cure, not all patients are eligible for the procedure, which is why a new experimental therapy, called CTL019, is raising hope for many.